Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2000
11/22/2000EP1053004A2 Use of angiotensin analogues for promoting erythropoiesis
11/22/2000EP1053003A1 Compositions and methods for separating lens epithelial cells and preventing posterior capsular opacification
11/22/2000EP1053002A1 Treatment of bony defects with osteoblast precursor cells
11/22/2000EP1053001A1 Novel mixed amylin activity compounds
11/22/2000EP1053000A1 Agents and methods for protection, treatment and repair of connective tissue
11/22/2000EP1052998A1 Compositions and methods for modulating cytokine release in response to genotoxic agents
11/22/2000EP1052994A2 Use of dipeptidylpetidase inhibitors to regulate glucose metabolism
11/22/2000EP1018875A4 Insecticidal peptides from segestria sp. spider venom
11/22/2000EP0866717A4 Oligodendrocyte-specific protein and method for treating disease
11/22/2000EP0722327B1 Improvements relating to antibacterial compositions
11/22/2000EP0703988B1 Mesothelial cell gene therapy
11/22/2000EP0669936B1 Mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace
11/22/2000EP0666753B1 Use of peptides FOR THE TREATMENT OF THE COMPLICATIONS AND PATHOLOGY OF DIABETES
11/22/2000EP0663823B1 Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors
11/22/2000EP0586535B1 Methods and compositions based on inhibition of cell invasion and fibrosis by dextran sulfate
11/22/2000CN1274387A HCVE mimotopes of hypervariable region 1 and uses
11/22/2000CN1274289A Compsns. comprising comjugates of stable, active, human ob protein with antibody FC chain and methods
11/22/2000CN1274288A Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors
11/22/2000CN1274285A Alpha-ketoamide multicatalytic protease inhibitors
11/22/2000CN1274284A Methods of modulating serine/threnoine protein kinase function with 5-azaquinoxaline-based compounds
11/21/2000US6150588 DNA encoding antimicrobial proteins from impatiens
11/21/2000US6150556 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
11/21/2000US6150547 Iron-casein complex hydrolyzate and process for the production thereof
11/21/2000US6150530 Amidation of amine with acid
11/21/2000US6150515 Nucleic acid of defined nucleotide sequence which encodes a tat-stimulatory factor protein; for drug screening of viricides for treatment of human immunodeficiency virus
11/21/2000US6150508 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
11/21/2000US6150506 Globin-like polypeptide having two dialpha domains; synthetic blood; antiischemic agents; antihypoxia agents; drug delivery; in vivo imaging; treatment of sickle cell anemia
11/21/2000US6150505 Preparing aqueous solution of fibrinogen, thrombin and factor xiii, before coagulation adding an oil heated to 50-80 degrees celsius to form emulsion, mixing until crosslinked microbeads are formed, isolating beads; glutaraldehyde-free
11/21/2000US6150503 Phosphorylated fusion proteins
11/21/2000US6150502 Polypeptides expressed in skin cells
11/21/2000US6150500 Activators of endothelial nitric oxide synthase
11/21/2000US6150461 Hyaluronic acid receptor; graft copolymer
11/21/2000US6150415 Epoxide hydrolase complexes and methods therewith
11/21/2000US6150398 By administering to a human a synergistic combination of paclitaxel and a dna crosslinking antineoplastic agent, such as cisplatin
11/21/2000US6150378 Peptidyl-containing α-ketoamide cysteine and serine protease inhibitors
11/21/2000US6150346 Method and composition for treating or preventing osteoporosis
11/21/2000US6150344 Useful for treatment of diseases such as malaria and alzheimer's disease; compounds are attached to a solid support
11/21/2000US6150342 Heparin derivatives for treatment of angina pectoris
11/21/2000US6150340 RNA-dependent amidotransferase from Staphylococcus aureus
11/21/2000US6150339 Anti-viral guanosine-rich oligonucleotides
11/21/2000US6150338 Delivery and expression of a recombinant vector containing a dna sequence encoding a protein involved in the regulation of smooth muscle tone into a smooth muscle cell
11/21/2000US6150335 Treatment for pain
11/21/2000US6150334 Serine protease inhibitors-tripeptoid analogs
11/21/2000US6150333 Treatment of certain diseases and conditions such as gastroenterological diseases, crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, vipoma, nesidoblastosis, hyperinsulinism
11/21/2000US6150332 Alpha1-antitrypsin and peptide fragments and derivatives thereof are used to upregulate low density lipoprotein cholesterol receptor levels in the liver, resulting in a decrease in circulating ldl cholesterol levels
11/21/2000US6150331 Human growth hormone-containing aqueous pharmaceutical composition
11/21/2000US6150330 Parenteral administration to the animal of a substantially aqueous biologically active bovine growth hormone releasing factor analog comprising at least 50 mg of said biologically active bovine hormone releasing factor analog in water
11/21/2000US6150329 Multimeric antithrombotic agents
11/21/2000US6150328 Purified bone morphogenic proteins-2 and 4 for use in the treatment of bone and cartilage defects and in wound healing and related tissue repair
11/21/2000US6150326 Means for treating autoimmune diseases and method for the treatment thereof
11/21/2000US6150325 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical compositions
11/21/2000US6150165 Polynucleotide which encodes a delta-endotoxin active against coleopteran pests; biological pest control; transgenic plants; treatment of plants and seeds
11/21/2000US6150162 Antisense modulation of CD44 expression
11/21/2000US6150153 Thermostable trehalose-releasing enzyme
11/21/2000US6150139 Preparing bactericide; culturing cells, separating the supernatant, separate bateriocin from supernatant, recover bacteriocin
11/21/2000US6150135 Dirofilaria and brugia thioredoxin peroxidase type-2 (TPX-2) nucleic acid molecules, and uses thereof
11/21/2000US6150134 Recombinant microorganism polypeptide; for the diagnosis, treatment and prevention of preferential microorganismal infections; for the purification of recombinant polypeptides
11/21/2000US6150132 Vector coding polypeptides for the diagnosis and treatment of allergies and atherosclerosis; for the prevention of graft ejection and injuries to stem cell caused by anticarcinogenic agents
11/21/2000US6150131 Screening for viricides that suppress interactions between cysteine and palmitic acid; mix cells infected with influenza virus, palmitic acid and modulator, monitor reduction in palmitic acid incorporation
11/21/2000US6150125 Flea protease proteins and uses thereof
11/21/2000US6150109 Lipophilic quenching of viral inactivating agents
11/21/2000US6150101 Methods of identifying a composition that alters connective tissue growth factor expression
11/21/2000US6150099 Detecting modulators of transcription factors; incubating transcription factor and modulator in solution, monitor the level of gene expression
11/21/2000US6150093 Unique associated Kaposi's sarcoma virus sequences and uses thereof
11/21/2000US6150092 Nucleotide sequences which suppress the activity of vascular endothelial growth factors; for diagnosis and treatment of solid tumors, arthritis, diabetes or cancers; anticarcinogenic, antitumor, antiarthritic agents
11/21/2000US6150091 Direct molecular diagnosis of Friedreich ataxia
11/21/2000US6150088 Core structure of gp41 from the HIV envelope glycoprotein
11/21/2000US6150081 Nucleated with peptizer
11/21/2000US6149946 Method and product using sturgeon notochord for alleviating the symptoms of arthritis
11/21/2000US6149945 Irradiating culture of normal, fibroblast cells with gamma rays; incubating said cells; releasing dna synthesis inhibiting factor (sif) or mitosis inhibiting factor (mif) from cells; centrifuging; concentrating supernatant
11/21/2000US6149936 DNA expression vectors for the use in the gene therapeutic treatment of vascular disorders
11/21/2000US6149919 Immunogenic detoxified mutants of cholera toxin and of the toxin LT, their preparation and their use for the preparation of vaccines
11/21/2000US6149916 Methods of accelerating wound healing or of stimulating connective tissue cell growth using connective tissue growth factor
11/21/2000US6149909 Synthetic α-L-iduronidase and genetic sequences encoding same
11/21/2000US6149908 Use of lactoperoxidase, a peroxide donor and thiocyanate for the manufacture of a medicament for treating Helicobacter pylori infection
11/21/2000US6149907 Treatments using sertoli cells
11/21/2000US6149903 Suppressing the growth of an epithelial ovarian tumor in a mammal by injecting a genetic engineered vector to an intraperitoneal cavity of the mammal at the site of tumor
11/21/2000US6149902 Manipulation of non-terminally differentiated cells using the notch pathway
11/21/2000CA2203694C Cancer inhibitory peptides
11/21/2000CA2159452C Needleless syringe using supersonic gas flow for particle delivery
11/21/2000CA2117528C Facilitated oxygen delivery in conjunction with hemodilution
11/21/2000CA2081482C Method and composition for treatment of central nervous system disease states associated with abnormal amyloid beta protein molecular organization
11/21/2000CA2038578C Delivery of agents
11/21/2000CA2027842C Treatment for multiple sclerosis with lymphocytapheresis and chemo-immunosuppression
11/21/2000CA2020477C Sustained release formulations of water soluble peptides
11/21/2000CA1341142C Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
11/16/2000WO2000068426A1 Ups
11/16/2000WO2000068399A2 Vector-mediated delivery of integrating transposon sequences
11/16/2000WO2000068387A2 Nucleic acids and proteins with interferon-beta activity
11/16/2000WO2000068386A1 Autotaxin variants and uses to treat diseases of metabolism
11/16/2000WO2000068385A2 Novel nucleic acids and proteins with growth hormone activity
11/16/2000WO2000068384A2 NOVEL NUCLEIC ACIDS AND PROTEINS WITH p53 ACTIVITY AND ALTERED TETRAMERIZATION DOMAINS
11/16/2000WO2000068383A2 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
11/16/2000WO2000068380A2 Extracellular matrix and adhesion-associated proteins
11/16/2000WO2000068379A1 Methods for treating tumors using antiangiogenic compounds
11/16/2000WO2000068378A1 Tall-1 nucleic acid molecules, proteins, receptors and methods of use thereof
11/16/2000WO2000068377A1 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use
11/16/2000WO2000068376A1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
11/16/2000WO2000068365A1 tRNA METHYLTRANSFERASES FROM STREPTOCOCCUS PNEUMONIAE
11/16/2000WO2000068363A2 Elastase variants and substrates
1 ... 2323 2324 2325 2326 2327 2328 2329 2330 2331 2332 2333 2334 2335 2336 2337 2338 2339 2340 2341 2342 2343 ... 3163